ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,420.26
-0.22%
Dow Jones
40,003.59
0.34%
Gold vs US Dollar
2,413.935
1.50%
Brent Oil
83.76
0.67%
Bitcoin
66,849.99
2.47%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Neurochem - Common Shares (MM) (NRMX)

  7. Neurochem - Common Shares (MM) (NRMX) News

Neurochem (NRMX)

Neurochem - Common Shares (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NRMX
DateTimeSourceHeadlineSymbolCompany
16/04/200816:57Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
15/04/200813:00PR Newswire (US)At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update oNASDAQ:NRMX
11/04/200821:27Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
11/04/200819:30PR Newswire (US)Media advisory - Neurochem's Annual and Special Meeting of Shareholders April 15, 2008NASDAQ:NRMX
11/04/200817:24PR Newswire (US)Neurochem Annual and Special Meeting of shareholdersNASDAQ:NRMX
10/04/200816:26Edgar (US Regulatory)Neurochem Inc - Amended Annual Report (foreign private issuer) (40-F/A)NASDAQ:NRMXNeurochem - Common Shares (MM)
20/03/200816:48Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
14/03/200821:23Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
14/03/200821:07Edgar (US Regulatory)Neurochem Inc - Annual Report (foreign private issuer) (40-F)NASDAQ:NRMXNeurochem - Common Shares (MM)
13/03/200819:25Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
13/03/200811:00PR Newswire (US)Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosisNASDAQ:NRMX
22/02/200819:10Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
22/02/200800:19PR Newswire (US)Neurochem announces departure of two members of management teamNASDAQ:NRMX
21/02/200821:54Edgar (US Regulatory)Neurochem Inc - Amended Report of Foreign Issuer (6-K/A)NASDAQ:NRMXNeurochem - Common Shares (MM)
21/02/200820:18Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
21/02/200800:12PR Newswire (US)Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectivesNASDAQ:NRMX
15/02/200820:45Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
13/02/200817:26PR Newswire (US)/C O R R E C T I O N from source -- Neurochem Inc./NASDAQ:NRMX
11/02/200820:55Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
11/02/200815:46PR Newswire (US)Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast liveNASDAQ:NRMX
30/01/200821:26Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
30/01/200813:00PR Newswire (US)Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical businessNASDAQ:NRMX
03/01/200820:59Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
03/01/200818:08PR Newswire (US)Neurochem to present at JPMorgan Healthcare ConferenceNASDAQ:NRMX
14/12/200720:51Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
14/12/200713:24PR Newswire (US)Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosisNASDAQ:NRMX
07/12/200722:25Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
06/12/200722:09PR Newswire (US)Neurochem announces eprodisate (KIACTA(TM)) receives acknowledgement of complete response and is granted Class 2 reviewNASDAQ:NRMX
03/12/200720:05Edgar (US Regulatory)Neurochem Inc - Report of Foreign Issuer (6-K)NASDAQ:NRMXNeurochem - Common Shares (MM)
30/11/200721:15PR Newswire (US)Neurochem announces departure of Dr. Philippe Calais, President, Global BusinessNASDAQ:NRMX
 Showing the most relevant articles for your search:NASDAQ:NRMX

Your Recent History

BIT
UC1GX4
Unicredit Bank
NYSE
TGNA
TEGNA
XE
3JPN
Leverage Shares Public
BINA
PNTBTC
USOTC
NBFJF
Nippon Building (PK)
TSXV
IMR
iMetal Resources
BIT
CCLD
Global X China Cloud Com...
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved